May 28, 2026 Parker Waichman LLP Files Lawsuit on behalf of Florida Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic and Mounjaro Parker Waichman, a national law firm, has now filed multiple lawsuits where each Plaintiff alleges that he or she developed NAION after
Clinical Trials: In Phase II and III cachexia studies, subjects received 13 mg/day for up to 12 weeks, resulting in significant increases in lean body mass and improved function Research Context: Other studies tested doses up to 9 mg/day, showing a clear dose-response effect on lean mass accrual
Multiple experiments indicate that GCL is the rate-limiting enzyme in the plant glutathione biosynthesis (Foyer et al., 1998)
Ipamorelin is a growth hormone-releasing peptide (GHRP), and some of the early research on animals is intriguingbut the studies are limited, and ipamorelin hasnt yet been approved for any medical use